Page last updated: 2024-10-15

n(5)-methyl-n(5)-formyl-2,5,6-triamino-4-hydroxypyrimidine

Description

N(5)-methyl-N(5)-formyl-2,5,6-triamino-4-hydroxypyrimidine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,6-diamino-4-hydroxy-5-(N-methylformamido)pyrimidine : A pyrimidine derivative having amino substituents in the 2- and 6-positions, a hydroxy substituent at the 4-position and an N-methylformamido group at the 5-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID135398708
CHEBI ID28643
SCHEMBL ID4620712
SCHEMBL ID8495863
MeSH IDM0112994

Synonyms (21)

Synonym
77440-13-2
mftahp
2,6-diamino-4-hydroxy-5-(n-methyl)formamidopyrimidine
C04744
CHEBI:28643
n-(2,4-diamino-6-hydroxypyrimidin-5-yl)-n-methylformamide
2,6-diamino-4-hydroxy-5-(n-methylformamido)pyrimidine
formamide, n-(2,6-diamino-1,4-dihydro-4-oxo-5-pyrimidinyl)-n-methyl-
n(5)-methyl-n(5)-formyl-2,5,6-triamino-4-hydroxypyrimidine
2,6-diamino-4-hydroxy-5-n-methylformamidopyrimidine
SCHEMBL4620712
2,6-diamino-4-hydroxy-5n-methyl-formamidopyrimidine
SCHEMBL8495863
me-fapygua
n5-methyl-n5-formyl-2,5,6-triamino-4-hydroxypyrimidine
n-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)-n-methyl-formamide
2,6-diamino-4-hydroxy- 5- formamidopyrimidine
Q27103805
n-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)-n-methylformamide
n-(6-amino-4-hydroxy-2-imino-1,2-dihydropyrimidin-5-yl)-n-methylformamide
DTXSID60998651
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
aminopyrimidineA member of the class of pyrimidines that is pyrimidine substituted by at least one amino group and its derivatives.
formamidopyrimidine
hydroxypyrimidine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]